Harry R. Trout III

Insider Reports History

Location
C/O Enanta Pharmaceuticals, Inc., 4 Kingsbury Avenue, Watertown, MA
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harry R. Trout III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Vice President, Finance (Principal Financial Officer) Common Stock 16.3K $233K $14.23 Dec 5, 2025 Direct
ENANTA PHARMACEUTICALS INC Vice President, Finance (Principal Financial Officer) Stock Option (right to buy) 12.9K Nov 25, 2025 Direct

Insider Reports Filed by Harry R. Trout III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENTA ENANTA PHARMACEUTICALS INC Dec 5, 2025 1 -$7.71K 4 Dec 5, 2025 Vice President, Finance (Principal Financial Officer)
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2025 2 -$6.79K 4 Dec 3, 2025 Vice President, Finance (Principal Financial Officer)
ENTA ENANTA PHARMACEUTICALS INC Nov 25, 2025 2 $0 4 Nov 26, 2025 Vice President, Finance (Principal Financial Officer)
ENTA ENANTA PHARMACEUTICALS INC Aug 26, 2025 0 $0 3 Sep 8, 2025 Vice President, Finance